The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer
dc.contributor.author | Geredeli, Caglayan | |
dc.contributor.author | Artac, Mehmet | |
dc.contributor.author | Kocak, Ismail | |
dc.contributor.author | Koral, Lokman | |
dc.contributor.author | Sakin, Abdullah | |
dc.contributor.author | Altinok, Tamer | |
dc.contributor.author | Kaya, Bugra | |
dc.date.accessioned | 2025-01-27T21:04:17Z | |
dc.date.available | 2025-01-27T21:04:17Z | |
dc.date.issued | 2020 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Context: The prognostic criteria for early-stage nonsmall cell lung cancer (NSCLC) wait to be explored. Aim: In this study, our aim was to evaluate the prognostic significance of the positron emission tomography/computed tomography (PET/CT) maximum standardized uptake value (SUVmax) value of the primary tumor in patients with a diagnosis of early-stage NSCLC who received surgical treatment. Settings and Design: This was a multicenter retrospective design. Materials and Methods: Patients who had been diagnosed with early-stage NSCLC and who underwent surgery for the condition were included in this study. The preoperative fluorodeoxyglucose (18F-FDG) PET/CT results of the patients were retrospectively accessed from their medical files. The disease-free survival (DFS) rates of patients who had SUVmax values above and below the determined cutoff value were compared. Statistical Analysis Used: SPSS version 22 and Kaplan-Meier method were used for statistical analysis. Results: A total of 92 patients were included in the study. The median age of the patients was 60 years (range: 36-79). The determined cutoff SUVmax value of the primary tumor was 13.6. A comparison of the DFS rates of the patients with an SUVmax value above and below 13.6 revealed a significant difference in patients with Stage I (22.9 months vs. 50.3 months; P = 0.02) and Stage II (28 months vs. 40.4 months; P = 0.04), Stage I + II (43.5 months vs. 26.1 months; P = 0,02), and Stage IIIA (14.7 months vs. 13.6 months; P = 0.92) NSCLC. Conclusions: We found that in early-stage NSCLC patients, the SUVmax value of the primary mass in 18F FDG PET/CT was a prognostic indicator for the DFS rates. | |
dc.description.sponsorship | Selcuk University Research Support System, Konya, Turkey | |
dc.description.sponsorship | This study was funded by Selcuk University Research Support System, Konya, Turkey. | |
dc.identifier.doi | 10.4103/jcrt.JCRT_911_17 | |
dc.identifier.endpage | 821 | |
dc.identifier.issn | 0973-1482 | |
dc.identifier.issn | 1998-4138 | |
dc.identifier.issue | 4 | |
dc.identifier.pmid | 32930124 | |
dc.identifier.scopus | 2-s2.0-85091051417 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 816 | |
dc.identifier.uri | https://doi.org/10.4103/jcrt.JCRT_911_17 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/27601 | |
dc.identifier.volume | 16 | |
dc.identifier.wos | WOS:000585412200019 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Wolters Kluwer Medknow Publications | |
dc.relation.ispartof | Journal of Cancer Research and Therapeutics | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | 18F-fluorodeoxyglucose positron emission tomography | |
dc.subject | computed tomography | |
dc.subject | early-stage nonsmall cell lung cancer | |
dc.subject | maximum standardized uptake value | |
dc.title | The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer | |
dc.type | Article |